Huntsman Cancer Institute (HCI) is part of University of Utah Health. Every year, HCI serves thousands of cancer patients from Utah and the surrounding states. HCI also teaches and trains future doctors, nurses, and scientists. HCI is the only National Cancer Institute-Designated Cancer Center in the Mountain West. This means it meets the highest national standards for cancer care and research and receives support for its scientific endeavors.

HCI is also a member of the National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of the world’s leading cancer centers. NCCN is dedicated to improving the quality and effectiveness of care provided to patients with cancer.

Thank You for Choosing HCI

We work hard to make sure you have an exceptional experience with the best possible results. We listen and respond to what you and other patients tell us. It is our mission to understand cancer from its beginnings, to use that knowledge in the creation and improvement of cancer treatments, to relieve the suffering of cancer patients, and to provide education about cancer risk, prevention, and care.

Recent News

In The Media

Why So Many Utah Men Have Melanoma

Utah has had the nation's greatest incidence of melanoma from 2010 to 2014, the last year for which data is available. Its rates of melanoma have more than doubled in the past 17 years, from 20 to 42 cases for every 100,000 people, according to the Utah Department of Health and the Utah Cancer Registry.

Read More

Press Releases

New Research on Sperm Stem Cells has Implications for Male Infertility and Cancer

New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah and collaborators at University of Utah Health (U of U Health) sheds light on the complex process that occurs in the development of human sperm stem cells. This is the first study to characterize the changes human sperm stem cells undergo as they mature. The results have implications for understanding male infertility as well as cancer development and were published today in the journal Cell Stem Cell.

Read More

Press Releases

Huntsman Cancer Institute Announces New Clinical Research Director

Huntsman Cancer Institute (HCI) at the University of Utah has announced David Gaffney, MD, PhD, as Senior Director for Clinical Research. In this position, Gaffney oversees HCI’s clinical research efforts which include more than 200 active clinical cancer trials at any given time.

Read More

In The Media

Scientists See Progress for Cancer Vaccines

Tumor-destroying vaccines have emerged as a new weapon in the fight against cancer. Conventional vaccines prevent people from getting sick in the first place. Now scientists are testing a new type of vaccine that treats existing cancers by spurring immune cells to go on the attack. These drugs—known as therapeutic vaccines—hold the potential to plunge cancers into remission without causing the side effects of treatments such as chemotherapy.

Read More